Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abroga

Author:  ["Markus F. Neurath","Sven Pettersson","Karl-Hermann Meyer Zum Büschenfelde","Warren Strober"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Chronic intestinal inflammation induced by 2,4,6,–trinitrobenzene sulfonic acid (TNBS) is characterized by a transmural granulomatous colitis that mimics some characteristics of human Crohn's disease. Here, we show that the transcription factor NF–κB p65 was strongly activated in TNBS–induced colitis and in colitis of interleukin–10–deficient mice. Local administration of p65 antisense phosphorothioate oligonucleotides abrogated clinical and histological signs of colitis and was more effective in treating TNBS–induced colitis than single or daily administration of glucocorticoids. The data provide direct evidence for the central importance of p65 in chronic intestinal inflammation and suggest a potential therapeutic utility of p65 antisense oligonucleotides as a novel molecular approach for the treatment of patients with Crohn's disease.

Cite this article

Neurath, M., Pettersson, S., Meyer Zum Büschenfelde, KH. et al. Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice. Nat Med 2, 998–1004 (1996). https://doi.org/10.1038/nm0996-998

View full text

>> Full Text:   Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abroga

During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tum

Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a co